Cholesterol pills work by either slowing your body’s production of cholesterol, blocking its absorption from food, or helping your body clear it from the bloodstream faster. The most commonly prescribed type, statins, can lower LDL (“bad”) cholesterol by 30% to 50% or more. But statins aren’t the only option. Several different classes of cholesterol medication exist, each targeting a different step in how your body makes, absorbs, or processes cholesterol.
Statins: Blocking Cholesterol Production in the Liver
Your liver manufactures most of the cholesterol in your body, and statins work by disrupting that manufacturing process. Specifically, they block a key enzyme that controls the pace of cholesterol production inside liver cells. When this enzyme is inhibited, liver cells end up with less cholesterol internally. That triggers a chain reaction: the liver compensates by pulling more LDL cholesterol out of your bloodstream. It does this by producing more LDL receptors on its surface, essentially building more “docking stations” to grab and remove LDL particles from circulation.
This is why statins are so effective. They don’t just slow production; they actively force the liver to scavenge cholesterol that’s already floating in your blood. High-intensity statin therapy can cut LDL levels by 50% or more, which is why statins remain the first-line treatment for most people with elevated cholesterol or heart disease risk.
Why Some Statins Should Be Taken at Night
Your liver produces more cholesterol overnight than during the day. Short-acting statins (like simvastatin and fluvastatin) are cleared from your body relatively quickly, so taking them in the evening ensures they’re active during peak production hours. A meta-analysis in the Journal of Clinical Lipidology found that evening dosing of short-acting statins lowered LDL significantly more than morning dosing. Long-acting statins like atorvastatin and rosuvastatin stay in your system long enough that timing matters less, so they can be taken whenever is most convenient for you.
Cholesterol Absorption Inhibitors
Not all cholesterol enters your bloodstream from your liver. A meaningful amount comes from what you eat and from bile that your digestive system recycles. Ezetimibe, the main drug in this class, works in the small intestine by blocking a specific transporter protein that shuttles cholesterol from your gut into your bloodstream. Without this transporter functioning normally, roughly 70% less cholesterol gets absorbed.
After you swallow ezetimibe, your body modifies it into an active form that circulates between the liver and intestine, returning repeatedly to its target site in the gut. This recycling keeps the drug working efficiently. On its own, ezetimibe lowers LDL by about 15% to 20%. That’s more modest than a statin, but the two drugs complement each other well. A statin reduces what the liver produces while ezetimibe reduces what the gut absorbs, so combining them tackles cholesterol from two different angles.
PCSK9 Inhibitors: Protecting LDL Receptors
Remember those LDL receptors on the liver that grab cholesterol from your blood? Your body naturally produces a protein called PCSK9 that breaks them down. It’s a built-in off switch: PCSK9 binds to the receptor, prevents it from recycling back to the liver’s surface, and sends it to be destroyed. Fewer receptors means less cholesterol clearance.
PCSK9 inhibitors are injectable medications (given every two to four weeks) that block this protein. With PCSK9 out of the way, LDL receptors survive longer and keep cycling back to the surface to pull more cholesterol out of the blood. The result is a dramatic drop in LDL, often 50% to 60% on top of whatever a statin is already doing. These medications are typically reserved for people at very high cardiovascular risk or those who can’t tolerate statins, partly because of their higher cost.
Bile Acid Sequestrants: Forcing the Liver to Use Its Cholesterol
Your liver converts cholesterol into bile acids, which it releases into your intestine to help digest fats. Normally, most of that bile gets reabsorbed and recycled back to the liver. Bile acid sequestrants are resins that bind to bile acids in the gut and prevent them from being reabsorbed. They’re essentially flushed out of the body.
This forces the liver to dip into its own cholesterol supply to manufacture replacement bile acids. As the liver’s cholesterol stores drop, it compensates by pulling more LDL from the bloodstream, similar to the downstream effect of statins. Bile acid conversion is actually the body’s main route for getting rid of cholesterol, so amplifying this process can meaningfully lower LDL levels.
Fibrates: Targeting Triglycerides
Fibrates work differently from the medications above because their primary target is triglycerides, not LDL cholesterol. They activate a receptor inside cells that controls how the body handles fatty acids. When this receptor is switched on, it ramps up the breakdown of fatty acids for energy and simultaneously reduces the liver’s production of triglyceride-rich particles.
Fibrates also boost the activity of an enzyme in the bloodstream that breaks down triglyceride-carrying particles, while suppressing a protein that normally slows that enzyme down. The combined effect, faster breakdown plus reduced production, is what makes fibrates effective at lowering triglycerides. They’re typically prescribed for people with very high triglyceride levels rather than for elevated LDL alone.
Bempedoic Acid: A Newer Alternative
Bempedoic acid is a newer oral medication that targets cholesterol production in the liver, like statins, but at an earlier step in the process. It blocks an enzyme that produces one of the raw materials the liver needs to build cholesterol. With less raw material available, cholesterol output drops, and the liver again responds by pulling more LDL from the bloodstream.
One notable feature of bempedoic acid is that it’s only activated inside the liver, not in muscle tissue. This matters because statin-related muscle complaints, while often not caused by the statin itself, are the most common reason people stop taking them. Bempedoic acid offers an alternative pathway for people who experience those symptoms. It’s often used in combination with ezetimibe for added effect.
How These Medications Are Combined
Current treatment guidelines set specific LDL targets depending on your cardiovascular risk. For people at moderate risk who haven’t had a heart attack or stroke, the goal is generally an LDL below 100 mg/dL. For those with existing heart disease, the target drops to below 70 mg/dL. People at the highest risk, such as those who’ve had multiple cardiovascular events, aim for below 55 mg/dL.
Reaching those lower targets often requires stacking medications. The typical sequence starts with a statin at the highest tolerated dose. If that’s not enough, ezetimibe is added. For people who still haven’t reached their goal, a PCSK9 inhibitor or bempedoic acid may be layered on. Each drug attacks a different part of the cholesterol cycle, so the effects compound rather than overlap.
Muscle Symptoms and Statins
About 10% of people taking statins report muscle aches or weakness, making it the most talked-about side effect of any cholesterol medication. But research has revealed something surprising: more than 80% of those cases aren’t actually caused by the statin. Studies using placebo-controlled designs, where patients don’t know whether they’re taking the real drug or a sugar pill, consistently show that muscle complaints occur at similar rates in both groups. This is known as the nocebo effect, where expecting side effects makes you more likely to experience them.
That said, true statin-related muscle symptoms do occur in a small percentage of people. If you experience persistent muscle pain or weakness, your doctor can try switching to a different statin, lowering the dose, or moving to a non-statin medication like bempedoic acid or ezetimibe. Stopping treatment entirely is rarely the best option, since the cardiovascular benefits of lowering LDL are substantial and well-established.